Lusis Biosciences, Inc.

Lusis Biosciences is a California-based leader in qPCR assays and instruments for molecular diagnostics. The company specializes in VeraPoint qPCR assays and Q-Vera instruments designed for infectious disease detection across respiratory, urinary, sexually transmitted, gastrointestinal, and bloodborne pathogen applications. Lusis develops multiplexing technology-enabled reagents that simultaneously detect multiple targets, with a catalog of over 30 key products and hundreds of additional targets. The company also manufactures nucleic acid extraction reagents and sample processing solutions. Operating in over 160 countries with 10,000+ laboratory customers, Lusis combines integrated development and manufacturing capabilities with dedicated customer support and field application scientist consultation to deliver cost-effective, accessible molecular diagnostic solutions for clinical and research laboratories.